Yi Wang

机构：Anhui Medical University, Chinese Academy of Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Capital Institute of Pediatrics, Institute of Physics, Tongji Hospital, Union Hospital, University of Chinese Academy of Sciences, Institute of Zoology, Huazhong University of Science and Technology, Tianjin Medical University · ORCID：0000-0002-2109-2157

发表论文 75 篇 · 总被引 1812 次 · h-index 23

代表论文

• Regulation of myofibroblast dedifferentiation in pulmonary fibrosis (2024 · Respiratory Research · 被引 44)
• Kynurenine acts as a signaling molecule to attenuate pulmonary fibrosis by enhancing the AHR-PTEN axis (2024 · Journal of Advanced Research · 被引 26)
• Dual Barrier‐Penetrating Inhaled Nanoparticles for Enhanced Idiopathic Pulmonary Fibrosis Therapy (2024 · Advanced Functional Materials · 被引 25)
• Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk (2024 · International Journal of Nanomedicine · 被引 18)
• Alpinetin ameliorates bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation (2024 · Biomedicine & Pharmacotherapy · 被引 12)
• Myo9b mutations are associated with altered dendritic cell functions and increased susceptibility to autoimmune diabetes onset (2023 · Nature Communications · 被引 11)